Treatment of palmoplantar keratoderma with continuous infusion 5-fluorouracil

被引：0
|
作者：
Lienemann, AO
Colucci, VJ [1 ]
Jones, MS
Trauscht, JM
机构：
[1] Univ Montana, Sch Pharm & Allied Hlth Sci, Missoula, MT 59812 USA
[2] Franciscan Hlth Syst, Tacoma, WA USA
[3] Western Montana Clin, Dept Dermatol, Missoula, MT USA
[4] Montana Canc Specialists, Missoula, MT USA
[5] Univ Washington, Seattle, WA 98195 USA
来源：
CUTIS | 2004年 / 73卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
GOAL To provide effective drug treatment for inherited punctate palmoplantar keratoderma (PPK) OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to 1. Explain the clinical presentation of PPK. 2. Describe the treatment options for patients with PPK. 3. Discuss the evidence-based support for using continuous infusion 5-fluorouracil to treat patients with PPK.
引用
收藏
页码：303 / 308
页数：6
相关论文
共 50 条
  • [1] INFUSION OF 5-FLUOROURACIL IN CYLINDROMA TREATMENT
    JOHNSON, RO
    LANGE, RD
    KISKEN, WA
    CURRERI, AR
    [J]. ARCHIVES OF OTOLARYNGOLOGY, 1964, 79 (06): : 625 - 627
  • [2] Fluctuation in Plasma 5-Fluorouracil Concentration During Continuous 5-Fluorouracil Infusion for Colorectal Cancer
    Matsumoto, Hideo
    Okumura, Hideo
    Murakami, Haruaki
    Kubota, Hisako
    Higashida, Masaharu
    Tsuruta, Atsushi
    Tohyama, Kaoru
    Hirai, Toshihiro
    [J]. ANTICANCER RESEARCH, 2015, 35 (11) : 6193 - 6199
  • [3] SALIVARY PASSAGE OF 5-FLUOROURACIL DURING CONTINUOUS INFUSION
    MILANO, G
    THYSS, A
    SANTINI, J
    FRENAY, M
    FRANCOIS, E
    SCHNEIDER, M
    DEMARD, F
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (03) : 197 - 199
  • [4] CONTINUOUS 5-FLUOROURACIL INFUSION IN REFRACTORY CARCINOMA OF THE BREAST
    HANSEN, R
    QUEBBEMAN, E
    BEATTY, P
    RITCH, P
    ANDERSON, T
    JENKINS, D
    FRICK, J
    AUSMAN, R
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (02) : 145 - 149
  • [5] Pharmacokinetic modulation of 5-fluorouracil: Emulating continuous infusion?
    Lokich, J
    [J]. CANCER INVESTIGATION, 1999, 17 (07) : 543 - 544
  • [6] Anaphylaxis following continuous 5-fluorouracil infusion chemotherapy
    Biswal, BM
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1999, 29 (05): : 743 - 744
  • [7] Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine
    Poorter, RL
    Bakker, PJM
    Veenhof, CHN
    [J]. PHARMACY WORLD & SCIENCE, 1998, 20 (02): : 45 - 59
  • [8] TREATMENT OF COLORECTAL-CANCER AND OTHER MALIGNANCIES WITH CONTINUOUS INFUSION OF 5-FLUOROURACIL
    BARBOUNIS, VP
    KALOFONOS, HP
    MUNRO, AJ
    MCKENZIE, CG
    SACKIER, JM
    EPENETOS, AA
    [J]. ANTICANCER RESEARCH, 1989, 9 (01) : 33 - 39
  • [9] Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma
    Chung, YS
    Yamashita, Y
    Inoue, T
    Matsuoka, T
    Nakata, B
    Onoda, N
    Maeda, K
    Sawada, T
    Kato, Y
    Shirasaka, T
    Sowa, M
    [J]. CANCER, 1997, 80 (01) : 1 - 7
  • [10] CONTINUOUS 5-FLUOROURACIL INFUSION IN ADVANCED GASTRIC-CARCINOMA
    MOYNIHAN, T
    HANSEN, R
    ANDERSON, T
    QUEBBEMAN, E
    BEATTY, P
    AUSMAN, R
    [J]. CLINICAL RESEARCH, 1987, 35 (06): : A864 - A864
12345